Clinical Trials Using Allogeneic CD19-OX40-CD3zeta-CAR-mbIL-15-expressing Natural Killer Cells NKX019
Review the clinical trials studying allogeneic cd19-ox40-cd3zeta-car-mbil-15-expressing natural killer cells nkx019 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-1 of
1
- Status: ActiveLocation: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York